Alkermes (ALKS) Cash from Operations (2010 - 2026)
Alkermes (ALKS) reported Cash from Operations of 165743000.0 for Q1 2026, down 267.74% year-over-year from 98811000.0 in Q1 2025, and down 197.46% quarter-over-quarter from 170069000.0 in Q4 2025.
Alkermes (ALKS) Cash from Operations (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has 17 years of Cash from Operations data on file, last reported at 165743000.0 in Q1 2026.
- Cash from Operations for Q1 2026 came in at 165743000.0, down 267.74% year-over-year; the trailing twelve-month figure through Mar 2026 was 256200000.0 (down 50.43% YoY), and the FY2025 annual result was 520754000.0, up 18.59% from the prior year.
- Cash from Operations declined to 165743000.0 in Q1 2026 per ALKS's latest filing, from 170069000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 215710000.0 in Q2 2023 and troughed at 165743000.0 in Q1 2026.
- A 5-year average of 71560705.88 and a median of 98811000.0 in 2025 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2023 and 2026: Cash from Operations soared 15853.28% in 2023, then tumbled 267.74% in 2026.
- A 5-year view of Cash from Operations shows it stood at 1047000.0 in 2022, then surged by 10142.31% to 107237000.0 in 2023, then soared by 77.55% to 190397000.0 in 2024, then dropped by 10.68% to 170069000.0 in 2025, then tumbled by 197.46% to 165743000.0 in 2026.
- Business Quant data shows ALKS's Cash from Operations at 165743000.0 in Q1 2026, 170069000.0 in Q4 2025, and 101672000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -40.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 401.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 463.30 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 145.80 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 13.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -165.74 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 125.13 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 89.36 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 52.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -165.74 Mn |
| Mar 31, 2026 | -165.74 Mn |
| Dec 31, 2025 | 170.07 Mn |
| Dec 31, 2025 | 170.07 Mn |
| Sep 30, 2025 | 101.67 Mn |
| Sep 30, 2025 | 101.67 Mn |
| Jun 30, 2025 | 150.20 Mn |
| Jun 30, 2025 | 150.20 Mn |
| Mar 31, 2025 | 98.81 Mn |
| Mar 31, 2025 | 98.81 Mn |
| Dec 31, 2024 | 190.40 Mn |
| Dec 31, 2024 | 190.40 Mn |
| Sep 30, 2024 | 81.59 Mn |
| Sep 30, 2024 | 81.59 Mn |
| Jun 30, 2024 | 146.03 Mn |
| Jun 30, 2024 | 146.03 Mn |
| Mar 31, 2024 | 21.11 Mn |
| Mar 31, 2024 | 21.11 Mn |
| Dec 31, 2023 | 107.24 Mn |
| Dec 31, 2023 | 107.24 Mn |